Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05919849 · ClinicalTrials.gov registry record · Phase 1

Supporting Parents in Affirming Their Children's Experiences of Stigma

A Phase 1 study of Parent-Child Relations, sponsored by Yale University.

Recruiting
Registry status
Phase 1
Development phase
129
Enrollment target
4
Study locations

NCT05919849 is a Phase 1 study of Parent-Child Relations that is actively recruiting participants, run by Yale University. The registered enrollment target is 129 participants, below the 318-participant average among 38 other Parent-Child Relations trials with a reported enrollment target (59% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05919849, a Phase 1 study of Parent-Child Relations, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
Phase 1
Development phase
129 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to develop and test two brief online writing interventions to improve parental acceptance of sexual and gender minority youth (SGMY) in the Southeast United States.

Conditions Studied

Interventions

  • BEHAVIORAL Brief online writing intervention
  • OTHER Control condition

Study Locations (4)

Connecticut

  • Yale University - New Haven

Maryland

  • University of Maryland - College Park

Tennessee

  • Vanderbilt University - Nashville

Other

  • Ben-Gurion University - Beersheba

Trial Details

FieldValue
Enrollment Target 129 participants
Start Date 2023-11-29
Est. Completion 2026-08-31
Phase Phase 1

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT05919849

The ClinicalTrials.gov registry entry for NCT05919849 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 318-participant average among 38 other Parent-Child Relations trials with a reported enrollment target (59% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parent-Child Relations appearing as the primary indexed condition, and to 2 interventions - of which Brief online writing intervention is the first listed.

NCT05919849 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Connecticut, Maryland, Tennessee.

Frequently Asked Questions

What is clinical trial NCT05919849 about?

NCT05919849 is a clinical study titled "Supporting Parents in Affirming Their Children's Experiences of Stigma". The purpose of this study is to develop and test two brief online writing interventions to improve parental acceptance of sexual and gender minority youth (SGMY) in the Southeast United States.

What is the current status of trial NCT05919849?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 129 participants. The study started on 2023-11-29. Estimated completion is 2026-08-31.

What conditions does trial NCT05919849 study?

This clinical trial studies the following conditions: Parent-Child Relations.

What interventions are being tested in trial NCT05919849?

The interventions under investigation include: Brief online writing intervention (BEHAVIORAL), Control condition (OTHER).

Who is sponsoring clinical trial NCT05919849?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05919849 being conducted?

This trial has 4 study locations across Connecticut, Maryland, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parent-Child Relations

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.